Navitoclax (ABT-263)
Navitoclax (ABT-263)
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
5 mg 10 mg
Product Availability
In-stock
Price
$118.00
Member price
Product Availability
In-stock
Price
$188.00
Member price
Quantity
- +
Product Overview
Product Name Navitoclax (ABT-263)
CAS923564-51-6
FormulaC47H55ClF3N5O6S3
MW974.61
AppearanceWhite to light yellow powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Navitoclax, also known as ABT-263, is an orally bioavailable, synthetic small-molecule antagonist of a subset of the B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 selectively binds to apoptosis suppressor proteins Bcl-2, Bcl-XL, and Bcl-w and prevents their binding to the apoptotic effectors Bax and Bak proteins, which may trigger apoptosis in tumor cells overexpressing Bcl-2, Bcl-XL, and Bcl-w.

Related literature
Related
Sorry, no related items
History
Ponatinib | AP24534
Navitoclax (ABT-263)
PEAQX | NVP-AAM077
Fluticasone Furoate | GW685698
Elacestrant (Synonyms: RAD1901)
Resveratrol | trans-Resveratrol | SRT501